Form 8-K EAGLE PHARMACEUTICALS, For: May 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Eagle Pharmaceuticals (EGRX) Tops Q1 EPS by 22c
May 9, 2016 7:46 AM EDTEagle Pharmaceuticals (NASDAQ: EGRX) reported Q1 EPS of ($0.06), $0.22 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $29.6 million versus the consensus estimate of $17.33 million.
Cash and cash equivalents were $78.3 million as of March 31, 2016.
For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.
... More


